IDEXX LABORATORIES INC /DE
IDXX · Nasdaq · CIK 0000874716
SIC 2835
In Vitro & In Vivo Diagnostic Substances
Category
Chemicals
Entity
operating
Incorp.
DE
Fiscal Y/E
1231
Source: SEC EDGAR · All filings on SEC →
Investment Indicators
ROE
65.99%
ROA
31.62%
D/E Ratio
1.09
Current Ratio
1.23
Gross Margin
61.80%
Operating Margin
31.60%
Net Margin
24.62%
Book Value/Share
$20.14
Financial Statements
In USD millions (per-share figures shown directly) · Financials as of: 2026-02-20
Income Statement
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 4,304 | 3,898 | 3,661 | 3,367 | 3,215 |
| Cost of Revenue | — | — | 1,471 | 1,363 | 1,326 |
| Gross Profit | 2,660 | 2,379 | 2,190 | 2,004 | 1,889 |
| Operating Expenses | 1,300 | 1,251 | — | — | — |
| Operating Income | 1,360 | 1,128 | 1,097 | 899 | 932 |
| Net Income | 1,059 | 888 | 845 | 679 | 745 |
| EPS (Basic) | 13.17 | 10.77 | 10.17 | 8.12 | 8.74 |
| EPS (Diluted) | 13.08 | 10.67 | 10.06 | 8.03 | 8.60 |
Balance Sheet
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | 3,351 | 3,293 | 3,260 | 2,747 | 2,437 |
| Current Assets | 1,414 | 1,400 | 1,495 | 1,101 | 956 |
| Cash & Equivalents | 180 | 288 | 454 | 113 | 144 |
| Total Liabilities | 1,745 | 1,698 | 1,775 | 2,138 | 1,747 |
| Current Liabilities | 1,149 | 1,068 | 952 | 1,236 | 764 |
| Long-term Debt | 450 | 618 | 698 | 770 | 851 |
| Total Equity | 1,605 | 1,595 | 1,485 | 609 | 690 |
Cash Flow
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating CF | 1,182 | 929 | 907 | 543 | 756 |
| Investing CF | -136 | -207 | -125 | -195 | -293 |
| Financing CF | -1,165 | -878 | -442 | -371 | -697 |
| CapEx | 125 | 121 | 134 | 149 | 120 |
📄 SEC Filings
Quarterly Report
10-Q
2026-05-05
Open →
Current Report
FORM 8-K
2026-05-05
Open →
Proxy Statement
DEF 14A
2026-03-27
Open →
Current Report
FORM 8-K
2026-03-26
Open →
Annual Report
10-K
2026-02-20
Open →
Current Report
8-K
2026-02-13
Open →
Current Report
FORM 8-K
2026-02-02
Open →
Current Report
FORM 8-K
2026-01-13
Open →
Current Report
FORM 8-K
2025-11-13
Open →
Quarterly Report
10-Q
2025-11-03
Open →
Current Report
FORM 8-K
2025-11-03
Open →
Current Report
FORM 8-K
2025-10-07
Open →
Quarterly Report
10-Q
2025-08-04
Open →
Current Report
FORM 8-K
2025-08-04
Open →
Current Report
FORM 8-K
2025-07-10
Open →
Other filings (85)
Insider Transaction
FORM 4
2026-05-14
Open →
Insider Transaction
FORM 4
2026-05-14
Open →
Insider Transaction
FORM 4
2026-05-14
Open →
Insider Transaction
FORM 4
2026-05-14
Open →
Insider Transaction
FORM 4
2026-05-14
Open →
Insider Transaction
FORM 4
2026-05-14
Open →
Insider Transaction
FORM 4
2026-05-14
Open →
Insider Transaction
FORM 4
2026-05-14
Open →
Insider Transaction
FORM 4
2026-05-14
Open →
Insider Transaction
FORM 4
2026-05-11
Open →
Insider Transaction
FORM 4
2026-05-11
Open →
Insider Transaction
FORM 4
2026-05-11
Open →
Insider Transaction
FORM 4
2026-05-11
Open →
Insider Transaction
FORM 4
2026-05-11
Open →
Insider Transaction
FORM 4
2026-05-11
Open →
Insider Transaction
FORM 4
2026-05-04
Open →
SCHEDULE 13G
xslSCHEDULE_13G_X02/primary_doc.xml
2026-04-30
Open →
ARS
ARS
2026-03-27
Open →
DEFA14A
DEFA14A
2026-03-27
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X02/primary_doc.xml
2026-03-27
Open →
PRE 14A
PRE 14A
2026-03-13
Open →
Insider Transaction
FORM 4
2026-03-05
Open →
Insider Transaction
FORM 4
2026-03-05
Open →
4/A
FORM 4/A
2026-03-03
Open →
144
xsl144X01/primary_doc.xml
2026-03-03
Open →
Insider Transaction
FORM 4
2026-03-02
Open →
Insider Transaction
FORM 4
2026-02-27
Open →
144
xsl144X01/primary_doc.xml
2026-02-26
Open →
144
xsl144X01/primary_doc.xml
2026-02-25
Open →
Insider Transaction
FORM 4
2026-02-19
Open →
Insider Transaction
FORM 4
2026-02-19
Open →
Insider Transaction
FORM 4
2026-02-17
Open →
Insider Transaction
FORM 4
2026-02-17
Open →
Insider Transaction
FORM 4
2026-02-17
Open →
Insider Transaction
FORM 4
2026-02-17
Open →
Insider Transaction
FORM 4
2026-02-17
Open →
Insider Transaction
FORM 4
2026-02-17
Open →
Insider Transaction
FORM 4
2026-02-17
Open →
Insider Transaction
FORM 4
2026-02-17
Open →
Insider Transaction
FORM 4
2026-02-17
Open →
Insider Transaction
FORM 4
2026-02-17
Open →
144
xsl144X01/primary_doc.xml
2026-02-17
Open →
144
xsl144X01/primary_doc.xml
2026-02-17
Open →
Insider Transaction
FORM 4
2026-02-11
Open →
144
xsl144X01/primary_doc.xml
2026-02-10
Open →
Insider Transaction
FORM 4
2026-02-03
Open →
Insider Transaction
FORM 4
2025-12-03
Open →
Insider Transaction
FORM 4
2025-11-10
Open →
144
xsl144X01/primary_doc.xml
2025-11-07
Open →
Insider Transaction
FORM 4
2025-11-03
Open →
3/A
FORM 3/A
2025-10-20
Open →
3
FORM 3
2025-10-14
Open →
Insider Transaction
FORM 4
2025-09-04
Open →
Insider Transaction
FORM 4
2025-09-03
Open →
Insider Transaction
FORM 4
2025-09-03
Open →
Insider Transaction
FORM 4
2025-08-26
Open →
144
xsl144X01/primary_doc.xml
2025-08-22
Open →
Insider Transaction
FORM 4
2025-08-14
Open →
5/A
FORM 5/A
2025-08-14
Open →
3/A
FORM 3/A
2025-08-14
Open →
Insider Transaction
FORM 4
2025-08-13
Open →
144
xsl144X01/primary_doc.xml
2025-08-12
Open →
Insider Transaction
FORM 4
2025-08-12
Open →
Insider Transaction
FORM 4
2025-08-12
Open →
Insider Transaction
FORM 4
2025-08-11
Open →
144
xsl144X01/primary_doc.xml
2025-08-11
Open →
Insider Transaction
FORM 4
2025-08-08
Open →
Insider Transaction
FORM 4
2025-08-08
Open →
Insider Transaction
FORM 4
2025-08-08
Open →
144
xsl144X01/primary_doc.xml
2025-08-08
Open →
144
xsl144X01/primary_doc.xml
2025-08-06
Open →
144
xsl144X01/primary_doc.xml
2025-08-06
Open →
144
xsl144X01/primary_doc.xml
2025-08-06
Open →
3
FORM 3
2025-07-18
Open →
UPLOAD
filename1.pdf
2025-07-07
Open →
Insider Transaction
FORM 4
2025-06-03
Open →
CORRESP
filename1.htm
2025-06-02
Open →
SD
SD
2025-05-30
Open →
Insider Transaction
FORM 4
2025-05-23
Open →
144
xsl144X01/primary_doc.xml
2025-05-21
Open →
UPLOAD
filename1.pdf
2025-05-21
Open →
Insider Transaction
FORM 4
2025-05-14
Open →
144
xsl144X01/primary_doc.xml
2025-05-13
Open →
Insider Transaction
FORM 4
2025-05-13
Open →
144
xsl144X01/primary_doc.xml
2025-05-09
Open →